A detailed history of Old Republic International Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Old Republic International Corp holds 608,750 shares of BMY stock, worth $31 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
608,750
Previous 608,750 -0.0%
Holding current value
$31 Million
Previous $33 Million 23.42%
% of portfolio
1.03%
Previous 1.3%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $496,919 - $592,962
-10,250 Reduced 1.66%
608,750 $31.2 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $1.29 Million - $1.55 Million
-21,000 Reduced 3.28%
619,000 $45.2 Million
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $10.7 Million - $12.5 Million
-181,000 Reduced 22.05%
640,000 $37.9 Million
Q1 2020

May 07, 2020

SELL
$46.4 - $67.43 $1.95 Million - $2.83 Million
-42,000 Reduced 4.87%
821,000 $45.8 Million
Q3 2019

Oct 31, 2019

BUY
$42.77 - $50.71 $2.22 Million - $2.64 Million
52,000 Added 6.41%
863,000 $43.8 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $9.5 Million - $10.5 Million
213,000 Added 35.62%
811,000 $36.8 Million
Q1 2019

Apr 26, 2019

BUY
$45.12 - $53.8 $10.4 Million - $12.4 Million
230,000 Added 62.5%
598,000 $28.5 Million
Q2 2018

Aug 03, 2018

BUY
$50.53 - $62.98 $7.98 Million - $9.95 Million
158,000 Added 75.24%
368,000 $20.4 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $11.6 Million - $13.4 Million
210,000
210,000 $13.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Old Republic International Corp Portfolio

Follow Old Republic International Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Republic International Corp, based on Form 13F filings with the SEC.

News

Stay updated on Old Republic International Corp with notifications on news.